The b 2 -adrenergic receptor is part of the catecholamine system, and variants at two polymorphic sites in the gene coding for the receptor (ADRB2) confer increased activity. Overstimulation of this receptor may alter brain development, and has been linked to autism in non-identical twins. The objective of this study was to determine whether alleles in ADRB2 are associated with diagnosis of autism in the Autism Genetic Resource Exchange (AGRE) population. Three hundred and thirty-one independent autism case-parent trios were included in the analysis. Subjects were genotyped at activity-related polymorphisms rs1042713 (codon 16) and rs1042714 (codon 27). Association between autism and genotypes at each polymorphic site was tested using genotype-based transmission disequilibrium tests, and effect modification by family and pregnancy characteristics was evaluated. Sensitivity to designation of the proband in each family was assessed by performing 1000 repeats of the analysis selecting affected children randomly. A statistically significant OR of 1.66 for the Glu27 homozygous genotype was observed. Increased associations with this genotype were observed among a subset of Autism Diagnostic Observation Schedule confirmed cases and a subset reporting experience of pregnancy-related stressors. In conclusion, the Glu27 allele of the ADRB2 gene may confer increased risk of autism and shows increased strength with exposure to pregnancy related stress.
Introduction
Autism is a developmental disorder involving impairments in social function and communication, repetitive behaviors, and restricted interests. Although the neurological changes underlying this disorder are not fully understood, several lines of evidence suggest that they originate during prenatal development (reviewed in Arndt et al. ). Neurotransmitters are thought to play a role as growth factors, with b-adrenergic agonists inhibiting proliferation while promoting differentiation. 2 Work with rodents shows that functional b-adrenergic receptors are expressed in the central nervous system during gestation, 3, 4 and research on the effects of exposure to terbutaline, a b 2 -adrenergic receptor agonist, has produced evidence that pharmaceutical stimulation of the receptor in the fetus alters patterns of brain development [5] [6] [7] [8] and could potentially increase risk for autism. 9 This suggests that other factors increasing stimulation of this receptor and the ensuing pathways, including functional polymorphisms in the receptor gene (ADRB2, also known as B2AR), may affect neurodevelopment and be associated with increased risk for autism.
The mechanism by which genetic susceptibility to overstimulation of the b 2 -adrenergic receptor may increase risk for alterations in neurodevelopment is similar to that by which terbutaline exposure might act (outlined in Garofolo et al., 5 Connors et al.,
balance between cell proliferation and differentiation during brain development, truncating one aspect of development in favor of another. Alternatively, negative developmental effects seen with terbutaline exposure may be the result of oxidative stress prompted by increased cellular metabolism occurring with receptor stimulation. 12 Although the mature ADRB2 develops the mechanisms of desensitization and downregulation to protect against overstimulation and its potential results, experiments in sheep and rats suggest that fetal receptors, including those in the brain, do not uniformly have these capabilities, 13, 14 and may actually become sensitized, so that their response is greater than that of mature receptors. Evidence that cellular effects of prenatal ADRB2 stimulation indeed may translate into functional differences later in life among humans has been observed in children whose mothers were given ADRB2-agonists for tocolysis: exposed children delivered at term have shown significant decrements in school performance, 15 and psychosocial and cognitive measures 16 relative to control children, although these differences were not seen in those delivered prematurely. 16 It may, therefore, be hypothesized that genetic polymorphisms that confer increased receptor response to stimuli will influence development, whether receptor stimulation comes from agonists of exogenous or endogenous origin.
The ADRB2 gene is located on chromosome 5q31-32. 17 Two non-synonymous single nucleotide polymorphisms (SNPs) in the coding region are common in the general population:
18 a G for A substitution in codon 16 (rs1042713) encodes the amino-acid glycine rather than arginine (Arg16-Gly), and a G for C substitution at codon 27 (rs1042714) codes for glutamic acid rather than glutamine (Gln27-Glu). 19 The effect of these genotypes on receptor responsiveness, desensitization and downregulation has been investigated in vivo. Vascular responsiveness (forearm blood flow and hand vein dilation) to ADRB2 agonists 20, 21 and mental stress or exercise 22 appears to be higher among Glu27 homozygotes in experimental situations involving healthy adult volunteers. Studies using the same agonist have also found higher responsiveness among Gly16 homozygotes versus Arg16 homozygotes or heterozygotes 20, 23 although not uniformly. 21 Additionally, Gly16 homozygotes were resistant to desensitization of vascular response (regardless of position 27 amino acid), 21 and showed delayed onset, in the short term, of desensitization of cardiac response 24 and of downregulation of lymphocyte receptor density. 25 Overall, these results suggest that presence of the Gly16 and Glu27 alleles may result in increased responsiveness of ADRB2 to ligand.
Connors et al. 9 presented preliminary data suggesting that overstimulation of ADRB2 during human pregnancy could be associated with risk for developing autism. Among non-identical twins exposed to the ADRB2-agonist terbutaline during gestation, a higher concordance for autism was found than among similar unexposed twins. They also found higher frequencies of the Gly16 and Glu27 polymorphisms in a small sample of these twin subjects with autism than expected based on reported population frequencies. 9 The primary objective of the present study was to investigate whether Gly16 or Glu27 alleles at these functional polymorphisms in the ADRB2 gene were associated with autism risk using a larger sample of autism families.
We included covariates in order to further explore the nature of any such relationship. Stress was considered as a factor that could have an important role in modifying the effects of ADRB2 polymorphisms. Exposure to stress increases endogenous levels of catecholamines, which are ligands for the ADRB2, and autism has been associated with an increased number of reported stressful events occurring during 21-32 weeks gestation. 26 It was hypothesized that an association between ADRB2 genotype and autism would be greatest among pregnancies in which the mother had experienced relatively higher levels of stress. Evidence for 'sex-sensitive risk loci' 27 suggests that dichotomizing families according to whether they include an affected female will increase sample homogeneity with regard to the presence of malespecific versus female-specific risk loci. Increased homogeneity should improve power to observe effects of any such loci. We examined whether an observed association between autism and ADRB2 genotype would differ based on such a dichotomy in order to determine whether any risk conferred by these polymorphisms appeared to segregate by sex of those affected with autism.
Materials and methods

Population
The population was selected from the Autism Genetic Resource Exchange (AGRE), 28 an autism family registry and biosample resource that includes families, primarily multiplex, that are affected by autism or related disorders including pervasive developmental disorders and Asperger syndrome. We included as cases only persons with a diagnosis of autism. Family pedigree, phenotypic and genotypic data are available, and genetic material can be obtained for further analysis.
Our sample of AGRE participants included 334 families available in November 2003 with at least one child diagnosed with autism. All diagnoses of autism are confirmed using the Autism Diagnostic InterviewRevised (ADI-R), 29 administered by trained interviewers. Additionally, the Autism Diagnostic Observation Schedule-Generic (ADOS-G) 30 has been administered to a subset of participants. For the primary analysis, we considered a case to have autism based on their having an ADI-R determined AGRE classification of 'Autism'. A restricted case definition of an ADI-R confirmed diagnosis of autism and an ADOS classification of autism was additionally considered. The sample was predominantly a white/ non-Hispanic population (70.4% of probands); 8.8% of probands were characterized as white/Hispanic, with race and ethnicity unknown for 13.6%, and the remainder belonging to other racial/ethnic groups.
Genotyping
Genotyping was performed using Taqman technology with reagents and assay designs supplied by Applied Biosystems (Applied Biosystems, Foster City, CA, USA). After exclusion of genotypes for all family members when Mendelian inconsistencies were detected (one family at codon 16, three families at codon 27 and three families at both loci), genotypes for at least one ADRB2 polymorphism were available for 331 (out of 334) complete case-parent trios. One hundred and sixty-eight cases who were full siblings of these probands were also genotyped. Additionally, genotypes were available for 115 unrelated parents from the AGRE registry who were not a part of our family sample. These parents were included in the assessment of allele/genotype frequencies, haplotype frequency, and assessment of Hardy-Weinberg equilibrium and linkage disequilibrium (LD) among founders. They were not included in any of the association analyses. Only the 331 autism case-parent trios were included in the main association analyses presented; siblings were excluded in order to maintain independence of observations.
Phenotypic data
Pedigree structure, gender and affected status for all subjects were obtained from the AGRE website. Additionally, for a subset of the subjects, physical and neurological examinations, and medical and family histories have been administered. 28 The 'Birth and Medical History' includes items pertaining to pregnancy characteristics and problems experienced by the mothers of affected children during the gestation of the child in question. Because stress increases levels of ADRB2 ligands, the effect of higher levels of stress may be magnified in those with a more responsive receptor genotype. Data from the 'Birth and Medical History' instrument were used to construct a general indicator for pregnancy-related stress based on medical factors. Information on life events generally considered in evaluating psychosocial stress, such as divorce, death of a family member or loss of a job, 31 was not available and was therefore not incorporated into a measure. At the time of access in November 2005, data from this questionnaire were available for 144 (41%) proband subjects in this study population.
Statistical analysis
Genotype, allele and haplotype frequencies, as well as fit to Hardy-Weinberg proportions, were assessed using the founders. Departures from Hardy-Weinberg proportions were tested via w 2 , and haplotype frequencies were estimated using the STATA command hapipf, 32 which uses an EM algorithm; D 0 was calculated and a likelihood ratio test was used to test for LD. Association between autism and genotype at each polymorphic site was tested using genotype-based transmission disequilibrium tests (TDT) in a conditional logistic regression framework. 33, 34 In this setting, genotypes of cases are compared to those of matched 'pseudo-sibling' controls. 'Pseudo-sibling' genotypes are those that could alternately have occurred in the case child (or its siblings), given the parental genotypes. Odds ratios (OR) and 95% confidence intervals (CI) for being a case were computed for each genotype relative to the lower activity homozygote, and likelihood ratio tests were used to assess the significance of including both genotypes in the model. Initial analysis was restricted to proband cases (first affected child per family according to study ID order) in order to maintain a sample of independent observations. Sensitivity of the results to this designation of the proband in each family was assessed by performing 1000 repeats of the analysis with randomly selected sets of probands. A point estimate and 95% 'confidence region' are given by the median, and 2.5-97.5th percentiles of the resulting distribution of OR.
To examine possible effect modification, covariates were incorporated into the conditional logistic regression model by including interaction terms between the covariate and each genotype. 35 Variables considered as effect modifiers were: (a) presence of one or more indicators of pregnancy related stress and (b) whether or not the family included a female affected with an autism spectrum disorder. Because catecholamines, levels of which are increased in response to stress, are endogenous ligands for ADRB2, it may be expected that an association of autism with ADRB2 genotypes conferring increased activity would be increased among women experiencing higher levels of stress during pregnancy. Complications during pregnancy may be expected to contribute to both the emotional and physical stress experienced by a mother during her pregnancy; therefore, report of severe infection or fever during pregnancy, vaginal bleeding during pregnancy, generalized edema, hypertension, albuminuria, gestational diabetes, eclampsia/pre-eclampsia, multiple pregnancy or abnormal fetal screen were considered indicators of pregnancy-related stress. A dichotomous variable was created to indicate whether or not the family of each subject included any female member with autism spectrum disorder (ASD) or autism according to the ADI-R-derived classification. Families were thus classified if they included a female affected with any autism spectrum disorder, although only persons with autistic disorder were included in the case group. For each model fit, stratum-specific OR and 95% CI were calculated for each genotype. All conditional logistic regression analyses were carried out using the SAS program (SAS, version 9.1; Cary, NC, USA). Likelihood ratio tests were used to compare models including interaction terms to those
Haplotype-based association tests were conducted using the hbat command within the program FBAT 1.5.5, 36 which compares the observed distribution of genotypes to that expected under a null hypothesis of no association, either with or without the presence of linkage. All cases were included, with the empirical variance option used to adjust for correlation between sibling genotypes. This was compared to the situation when only proband cases were included. The additive model was used, because this method has been shown to be robust even when it does not hold. 37 
Results
Genotype counts and frequencies among founders are shown in Table 1 and are similar to population frequencies observed in the literature. [38] [39] [40] Both polymorphisms showed Hardy-Weinberg proportions among the founders. Haplotype frequencies among founders are given in Table 2 , and indicate high LD between these polymorphisms (D 0 = 0.99; P-value < 0.0001; r 2 = 0.42). Results of genotypic TDT tests are given in Table 3 . As only trios with at least one heterozygous parent are informative for these analyses, from 331 independent trios, 242 proband-parent trios each contributed to codon 16 and codon 27 analyses. Among the primary probands (Table 3 , OR1), a trend of increased risk with number of copies of the Gly16 or Glu27 allele was seen. A statistically significant association was observed between autism and the Glu27 homozygous genotype, with an OR of 1.66, and a 95% CI of 1.07-2.58. The likelihood ratio test for the joint effect of codon 27 polymorphisms was marginally significant (P = 0.08). For codon 16, there was an increased risk associated with the Gly16 homozygous genotype; however, this did not reach statistical significance. Because genotypes of additional full siblings affected with autism were available, the genotypic TDT was repeated 1000 times with random inclusion of one case from each family, in order to determine whether the observed association was specific to probands in these families. This resulted in a similar, but slightly attenuated median OR of 1.31 (1.02-1.66) ( Table 3 , OR2) for the Glu27 homozygous genotype.
Among the group that was positive for pregnancyrelated stress, the OR for the Glu27 homozygous genotype was elevated at 3.03 (95% CI = 1.15-7.98) versus an OR of 1.07 in the group that was negative for stress. Among the group without an affected female in the family, the Glu27 homozygous genotype was statistically significant, whereas among the group where families included affected females it was not. ADOS classifications were available for 179 probands (54%) originally classified by the ADI-R as having autism. According to the ADOS, 142 (79%) of these subjects were classified as having autism, whereas 25 (14%) were classified as having an ASD, and 12 (7%) as having neither autism nor an ASD. In some families where the proband did not meet the stricter case definition including an ADOS classification of autism, there was a sibling who did, resulting in a total of 169 available case-parent trios for the restricted analysis. Results given in Table 4 show similar patterns to those from the ADI-R defined case group, with somewhat stronger OR for the association of autism with the Glu27 homozygous genotype. Among primary probands, an OR of 2.4 was observed for the Glu27 homozygous genotype, with a statistically significant likelihood ratio test (P = 0.02) for a genotype effect at codon 27. Among the group that was positive for pregnancy-related stress, the OR for Glu27 homozygous genotype was 7.18; although statistically significant, this estimate had a wide CI. Here, there was a statistically significant association of the Gly16 homozygous genotype with autism in the random replicates analysis (OR = 1.94) and among families that did not include affected females (OR = 2.61).
Based on the observed LD and haplotype frequencies for these two SNPs (Table 2) , the Glu27 allele only occurs in one haplotype. Therefore, haplotype association analyses will not further parse the Glu27 association. As expected, haplotype analysis in FBAT showed similar results to the single SNP findings in Table 3 (results not shown). 
Discussion
An increased risk for autism associated with the homozygous Glu27 genotype for ADRB2 was observed. With the application of the more stringent diagnostic criteria of an 'autism' classification according to the ADOS as well as the ADI-R, the observed association of increased risk with the homozygous Glu27 genotype became stronger and remained statistically significant. This also was the case in subgroup analyses. The risk ratio for the Gly16 homozygous genotype increased as well and approached statistical significance. These changes were seen despite decreased sample size. The ADI-R is an interview instrument ascertaining caregiver report of behaviors both current and occurring in early childhood, 29 whereas the ADOS is a structured observational assessment of social interaction, communication, play and imaginative activity 30 as demonstrated at the time of test administration. Subjects concordant on the ADI-R and ADOS represent cases least likely to be false positives. These observations are consistent with those made previously by Connors et al. 9 and strongly support the hypothesis that overstimulation of the b 2 -adrenergic receptor during Bold values indicate statistical significance at a = 0.05. a OR2: 95% confidence region from estimates resulting from 1000 repeated analyses. b ' þ ' denotes families including an affected female; 'À' denotes families with affected males only. c P-value for likelihood ratio test (2 df) of genotype effect (OR1), or of interaction (OR3, OR4, OR5).
ADRB2 gene variants and autism risk in AGRE K Cheslack-Postava et al gestation can lead to changes in nervous system development and contribute to the risk for autism. Overstimulation of the ADRB2 by agonists has been associated with apoptosis, and altered cell replication, differentiation, morphology and distribution. 5, 6, [41] [42] [43] The Glu27 and Gly16 alleles that were associated with autism in the current study have been associated with increased responsiveness to b 2 -agonist and delayed desensitization and downregulation in vivo. These more responsive alleles may increase vulnerability to overstimulation and its associated effects, which in turn may increase risk for autism by altering neural architecture. Neural cells have shown differential response to b 2 -agonist by brain region, with sensitization occurring specifically in the brainstem and cerebellum; 44 meanwhile cerebellar abnormalities are one of the most consistently reported neuroanatomic findings in autism. 45 If polymorphisms in the ADRB2 gene increase the risk for autism through a mechanism involving overstimulation of the receptor, one would expect to observe a stronger association with genotype among groups exposed to higher levels of receptor ligands such as terbutaline or catecholamines. We considered maternal stress as a proxy for endogenous catecholamine exposure, and observed an increased risk for the Glu27/Glu27 genotype among the group positive for a variable constructed as a rough measure of pregnancy related stress. However, power for this hypothesis was decreased because data were not available for all subjects, so that specific sources of stress, such as infection, or timing by trimester could not be investigated. Two shortcomings limit the interpretation of the pregnancy stress variable as a measure of maternal stress. Although multiple domains -from the occurrence of life events, 31 to pregnancy-specific daily events, 46 to the experience of racism 47, 48 -are expected to contribute to overall stress, data to assess the influence of these factors were not available. Additionally, individual physiological stress responses to experienced events will vary and are influenced by a complex set of factors including genetics, personality, prior experience, social support and personal perception of these events, 49 ,50 which are also not considered here. Despite these limitations, the advantage of using the pregnancy stress variable was that it permitted use of the data available to address, if only generally, the question of interaction between maternal stress and ADRB2 genotype. The fact that a significant result was found despite these limitations suggests that this hypothesis merits further investigation with more accurate measures of prenatal stress.
Maternal ADRB2 genotype has been investigated in relation to risk for pre-term labor and birth, with the Gly16 51, 52 and Glu27 53 alleles being associated with higher risk, whereas autism has been associated with premature birth in some [54] [55] [56] though not all 57, 58 studies. The observed association between Glu27 homozygous genotype and autism, therefore, could possibly be explained by maternal genotype, mediated through prematurity. However, among proband cases for whom gestational age was available, the association of Glu27 with autism risk was similar to overall results after premature individuals ( < 37 weeks gestational age) were removed (data not shown). Therefore, mediation by gestational age does not appear to explain results. We selected for genotyping the two loci in the coding region of ADRB2 known to have functional polymorphisms that are common in the population and therefore they should be interpreted as direct tests of association rather than simply markers of this gene. However, it is certainly possible that the association detected may be a result of some nearby unmeasured variant that is also in LD with these functional polymorphisms. There are two other polymorphisms in the coding region of this gene that lead to amino-acid substitutions; however, they are rare, with the Met34 variant occurring in less than 1% of the population and the Ile164 variant occurring in 3-6%. 18 The Ile164 allele is associated with the Gly16/Gln27 haplotype 59, 60 so it is unlikely to account for our observation of an association of autism with the Glu27 homozygous genotype. However, we did not cover the entire gene with SNPs or screen for mutations, so the possibility that autism is associated with an alternate locus in the gene cannot be ruled out based on these results. Further, because the two loci studied are in strong LD, separating their effects may be difficult. The Gly16 allele also showed a trend towards increased risk, although the association was not statistically significant. This is likely due to an attenuation of the observed risk of the Gly16-Glu27 haplotype by the Gly16-Gln27 haplotype.
Although tests of association were repeated in case subgroups, we did not use multiple inference methods or make adjustments for multiple statistical testing. This is because we felt each measure of association (for each polymorphism in the full sample and in the samples stratified by covariates) was of some independent interest -in other words, we were not interested in testing an overall joint null hypothesis that all of these ORs were equal to 1.0. 61 In the case of interaction hypotheses, we did perform and report more stringent tests of interaction as well as showing 95% CIs for each stratum-specific test. Finally, 11 probands and three additional siblings in our sample were included previously in a small published analysis. 9 We included these subjects in our primary analysis because we were not strictly replicating results. Although the prior paper generated the hypothesis for this analysis, we performed a different type of analysis (TDT) incorporating information on parental genotypes. Additionally, because the previous sample was not selected randomly, but instead included specifically dizygotic twins, simply excluding these observations would have resulted in a sample not representative of the full study population. However, excluding these observations as a sensitivity analysis results in OR = 1.59 (1.01-2.50) for the Glu27 homozygote in the primary analysis and ADRB2 gene variants and autism risk in AGRE K Cheslack-Postava et al OR = 2.34 (1.24-4.41) for the Glu27 homozygote in the ADOS-confirmed case analysis. Strengths of this study include having a large population of over 330 families in which a consistent and reliable method of diagnosing autism was applied and genotype data was present for both parents of cases. Additionally, some pregnancy history information was available for a subset of the cases. The population is reasonably homogenous with respect to race/ethnicity; nonetheless, the statistical tests used avoid the potential for confounding owing to population stratification by conditioning on parental or familial genotypes. Autism is etiologically heterogeneous, and the finding of a stronger association in male-case only families may help define the subset of cases in which ADRB2 genotype may be a risk factor. However, the study is limited by the extent of the covariate data available. Pregnancy history data came from a retrospective interview and were available for only a subset of cases; biomarkers or more general measures of psychosocial stress are not available.
Furthermore, although the ADRB2 alleles found to be associated with autism in this population have exhibited increased responsiveness to agonist in vivo, results seen in adult cardiac and vascular systems may or may not coincide with those occurring in the fetal or neonatal nervous system. Substantial variation in response across systems tested has already been noted (reviewed by Leineweber and Brodde 18 ). Studies of the polymorphisms of ADRB2 in the human fetus and neonate are lacking. Literature review reveals just one study relating the Glu27 polymorphism and cerebral palsy in very premature infants ( < 32 weeks). 62 Future work in models relevant to the developing nervous system will be needed to determine the biological relevance of these results.
In summary, these results suggest that ADRB2 polymorphisms could play a role in risk for autism, and that such risk may be modified by maternal stress. Further study will be needed to elucidate the biological role of these polymorphisms in human brain development, to determine the characteristics of the case subset in which ADRB2 is associated with autism risk, and to fully investigate the role of maternal stress or other, endogenous ADRB2 agonists as effect modifiers.
